Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2018 Feb;15(2):1193-1198.
doi: 10.3892/etm.2017.5521. Epub 2017 Nov 16.

PTX3 in serum induces renal mesangial cell proliferation but has no effect on apoptosis

Affiliations

PTX3 in serum induces renal mesangial cell proliferation but has no effect on apoptosis

Danhuan Zhang et al. Exp Ther Med. 2018 Feb.

Abstract

The present study aimed to investigate the effect of pentraxin 3 (PTX3) on the regulation of proliferation and apoptosis in human glomerular mesangial cells (HMCs). Small interfering (si)RNA was designed and synthesized to inhibit the expression of endogenous PTX3, and the effects on the proliferation and apoptosis of HMCs were detected by flow cytometry and an MTT assay. Western blot analysis was used to detect the activation of mitogen-activated protein kinase (MAPK) proteins in HMCs with PTX3 knockdown. Three siRNAs targeting PTX3 were individually transfected into HMCs for 48 h, and reverse-transcription quantitative PCR demonstrated that the relative mRNA expression of PTX3 was significantly decreased in all groups by up to 79.62% of that in the control group (P<0.05). Following transfection with PTX3-siRNA, the viability of an HMC line was significantly decreased in comparison with that of a control group transfected with scrambled siRNA. However, PTX3-siRNA did not significantly effect early and late apoptotic cell populations in HMCs compared with those in the control. Endogenous PTX3 interference was found to significantly decrease p38 MAPK, extracellular signal-regulated kinase 1/2 and c-Jun N-terminal kinase phosphorylation. In conclusion, silencing of PTX3, inhibited the proliferation of HMCs via MAPK pathways, but exerted no effect on the apoptosis of HMCs.

Keywords: apoptosis; glomerular mesangial cells; pentraxin 3; proliferation.

PubMed Disclaimer

Figures

Figure 1.
Figure 1.
siPTX3 significantly reduced the expression of PTX3 mRNA in human glomerular mesangial cells. **P<0.01 vs. Scramble. PTX3, pentraxin 3; siPTX3, small interfering RNA targeting PTX3.
Figure 2.
Figure 2.
Human glomerular mesangial cell proliferation in Scramble, siPTX3-1, siPTX3-2 and siPTX3-3 groups. OD450, optical density at 450 nm; siPTX3, small interfering RNA targeting pentraxin 3. *P<0.05 vs. siPTX3-1, −2 and −3.
Figure 3.
Figure 3.
siPTX3 had no significant effect on the apoptosis of human glomerular mesangial cells. siPTX3, small interfering RNA targeting pentraxin 3; FITC, fluorescein isothiocyanate; PI, propidium iodide.
Figure 4.
Figure 4.
Protein levels of p38 MAPK, JNK and ERK1/2 as well as their phosphorylated forms in human glomerular mesangial cells. Phosphorylation of p38 MAPK, JNK and ERK1/2 were significantly reduced after knockdown of PTX3. *P<0.05, **P<0.01 vs. Scramble. MAPK, mitogen-activated protein kinase; p-ERK, phosphorylated extracellular signal-regulated kinase; JNK, c-Jun N-terminal kinase; PTX3, pentraxin 3; siPTX3, small interfering RNA targeting PTX3.

Similar articles

Cited by

References

    1. Suzuki D, Toyoda M, Kimura M, Miyauchi M, Yamamoto N, Sato H, Tanaka E, Kuriyama Y, Miyatake H, Abe M, et al. Effects of liraglutide, a human glucagon-like peptide-1 analogue, on body weight, body fat area and body fat-related markers in patients with type 2 diabetes mellitus. Intern Med. 2013;52:1029–1034. doi: 10.2169/internalmedicine.52.8961. - DOI - PubMed
    1. Zaza G, Granata S, Rascio F, Pontrelli P, Dell'Oglio MP, Cox SN, Pertosa G, Grandaliano G, Lupo A. A specific immune transcriptomic profile discriminates chronic kidney disease patients in predialysis from hemodialyzed patients. BMC Med Genomics. 2013;6:17. doi: 10.1186/1755-8794-6-17. - DOI - PMC - PubMed
    1. Witasp A, Rydén M, Carrero JJ, Qureshi AR, Nordfors L, Näslund E, Hammarqvist F, Arefin S, Kublickiene K, Stenvinkel P. Elevated circulating levels and tissue expression of pentraxin 3 in uremia: A reflection of endothelial dysfunction. PLoS One. 2013;8:e63493. doi: 10.1371/journal.pone.0063493. - DOI - PMC - PubMed
    1. Zhou Y, Ni Z, Zhang J, Zhang W, Wu Q, Shen G, Wang Y, Qian J. Plasma pentraxin 3 may be a better marker of peripheral artery disease in hemodialysis patients than C-reactive protein. Vasc Med. 2013;18:85–91. doi: 10.1177/1358863X13483864. - DOI - PubMed
    1. Lech M, Römmele C, Gröbmayr R, Eka Susanti H, Kulkarni OP, Wang S, Gröne HJ, Uhl B, Reichel C, Krombach F, et al. Endogenous and exogenous pentraxin-3 limits postischemic acute and chronic kidney injury. Kidney Int. 2013;83:647–661. doi: 10.1038/ki.2012.463. - DOI - PubMed